You are here: Industry Insights > lupin

News List

Lupin Q1 net profit up 49 pc to Rs 303.05 expresspharma
August 08, 2019
Lupin has reported a 49.46 per cent rise in consolidated net profit to Rs 303.05 crore for the quarter ended June 30, 2019 on account of robust sales in India and overseas.
Lupin’s Mandideep facility inspection completed by ANSM expresspharma
August 07, 2019
Drug firm Lupin on Tuesday said inspection of a unit of its Mandideep facility in Madhya Pradesh by the French National Agency for Medicines and Health Products Safety (ANSM) has been completed with no major observations.
Lupin gets EIR from USFDA for Aurangabad facility expresspharma
August 05, 2019
Drug firm Lupin said that it has received an Establishment Inspection Report (EIR) from the US health regulator for its Aurangabad facility in Maharashtra.
Lupin’s Nagpur facility won ENR Global Best Project Award expresspharma
July 23, 2019
Lupin has announced that it has won the Engineering News- Record’s (ENR) Global Best Project Award of Merit in the Manufacturing category. The award was given to Lupin’s Oral Solid Dosage (OSD) and Injectable Pharmaceutical Manufacturing Facility at Nagpu
Lupin aims to launch new products across geographies this fiscal expresspharma
July 18, 2019
Drug maker Lupin aims to launch its first biosimilar product and commercialise its first inhalation product in the US in the current fiscal. Addressing shareholders in the company’s Annual Report for 2018-19 ...
Lupin receives US FDA approval for Phenylephrine and Ketorolac Intraocular Solution expresspharma
July 05, 2019
Lupin’s Phenylephrine and Ketorolac Intraocular Solution, 1 per cent 0.3 per cent is the generic version of Omidria Intraocular Solution, 1 per cent 0.3 per cent of Omeros Corporation
LEO Pharma Completes Acquisition of Bayer’s Prescription Dermatology Business expresspharma
July 04, 2019
Lupin’s Phenylephrine and Ketorolac Intraocular Solution, 1 per cent 0.3 per cent is the generic version of Omidria Intraocular Solution, 1 per cent 0.3 per cent of Omeros Corporation
Lupin receives tentative US FDA approval for Mirabegron ER Tablets expressbpd
July 01, 2019
Lupin’s Mirabegron ER Tablets, 25 mg and 50 mg, is a generic version of Myrbetriq Extended Release Tablets, 25 mg and 50 mg, of Astellas
Lupin recalls over 18,000 bottles of antibiotic drug in US expresspharma
June 21, 2019
Drug major Lupin is recalling over 18,000 bottles of Cefdinir for Oral Suspension, used to treat bacterial infections, from the US market.
Japan’s PMDA completes inspection of Lupin’s Mandideep facility (Unit-2) biospectrumasia
June 05, 2019
Pharma major Lupin has announced the completion of the Good Manufacturing Practices (GMP) inspection of its Mandideep facility (Unit-2), by the Pharmaceutical and Medical Devices Agency (PMDA), Japan.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 19 20 Next page